Friends of Asthma, a registered charity in Ireland, is committed to
providing support for asthma sufferers and is involved with the ongoing
investigation of treatments for those affected. It is with great excitement that they have announced the results of a trial undertaken with Cellfood Concentrate.

About 500,000 people in Ireland, and 5.2 million people in the UK, suffer from asthma.

That is around 12% and 8% respectively of the population of both countries. The incidence of asthma is higher in children than adults and the number of asthma sufferers has been rising in recent decades.

Asthma can be controlled through medication. Reliever inhalers (for relaxing the muscles around the airways), preventer inhalers (steroids for controlling the sensitivity of the airways to attack) and steroid tablets (to calm inflamed airways) are typically used.

However, the medicines can have short and long term side effects (such as increased heart rate with relieving inhalers and bloating, hunger and mood swings with steroids).

Cellfood Concentrate is a nutritional supplement in a colloidal solution based on oxygen, trace minerals, amino acids and enzymes made from 100% natural sources. A number of anecdotal reports that Cellfood Concentrate could benefit asthma sufferers were circulating, both in the UK press1 and through asthma sufferers networking amongst themselves. Other studies on Cellfood Concentrate indicated that Cellfood improved the Prima Magazine December 2003; Health Plus March 2005. supply and use of oxygen in athletes2 and could be of benefit in the relief of Fibromyyalgia (including fatigue and pain through inflamed tissue and muscles)3. A further study into another oxygen product Vitamin O indicated that oxygen therapies improved lung function4 (a key consideration for asthma sufferers).

As result of these reports, Friends of Asthma decided to run a trial overseen by Dr Jackie Paul into the efficacy of Cellfood Concentrate and patients with asthma. The findings of the trial substantiate the experiences of other asthma sufferers who have related their stories in recent months (see attached case studies). All the patients who took part in the trial had been suffering asthma for a number of years.

They took Cellfood Concentrate for three months5. Their peak flow6 readings and oxygen levels7 were measured at the beginning and at the end of the trial. They were also asked for their perceptions of the number of attacks they suffered, the frequency with which they took medication and any other observations they felt relevant.

Following their three months of taking Cellfood Concentrate, the participants had significantly higher peak flow readings:
• All (100%) participants registered an increase in peak flow readings.
• The average increase was 30% - from 260 before the trial to 340 after the trial.
• The smallest increase was 11% - from 360 to 400.
• The largest increase was 66% - from 150 to 250.
• 50% of the participants showed increases between 25-40%.

Peak flow indicates the strength of the lungs and higher readings tend to mean fewer asthma attacks and attacks of less severity because the airways are wider and better able to combat the allergens and other particles that trigger an attack. There are three key findings here:
1. All participants recorded an increase in peak flow readings suggesting that Cellfood Concentrate is effective as a way to improve lung function
2 Product Efficacy Report: Cellfood by Kim De’Ath, Heinrich Nolte, Dr Johan Van Heerden, Sports Institute, University of Pretoria 2002.
3 Efficacy of CELLFOOD (Deutrosulfazyme) in patients diagnosed with Fibromyalgia, Department of Clinical Medicine and Immunology Sciences, University of Siena 2006.
4 Study into Vitamin O by Dr John Heinerman, Anthropological Research Center, Utah 2002. The study showed a 17-32% increase in arterial blood oxygen (PaO2). Patients with fatigue syndrome showed improved lung function.
5 Cellfood Concentrate is taken as 8 drops in a 200ml glass of bottled or filtered water three times a day.
6 Peak flow measures lung function. A Mini Wright Peak Flow Metre was used for the trial.
7 Oxygen levels were measured by an Oxymeter.

2. Only one other non-drug treatment appears to be able to increase peak flow readings and that is IMT – inspiratory muscle training. However, studies have shown that the typical increase from IMT is around 11%, a third of the results Cellfood Concentrate returned8.

3. Higher peak flow readings should translate into a reduction of asthma and a measurable improvement on the quality of life. This appears to be borne out by the comments from the participants that most used their inhalers less frequently whilst taking Cellfood Concentrate. If this is the case, then Cellfood Concentrate is one of only a very few treatments that can actually reduce the number of asthma attacks.

Likewise, the oxygen levels in the blood went up:
• All (100%) participants showed an increase in oxygen levels.
• The average increase was 7% - from 91% to 97.6%.
• The smallest increase was 5% - from 95% to 99%.
• The largest increase was 8.8% - from 90% to 98%.
• 58% of participants showed an increase of 6.5%

The oxygen reading results bear out the manufacturer’s claims that Cellfood Concentrate generates oxygen in the body. The increases recorded by the participants brought them into line with readings for averagely healthy people. Oxygen levels are important because low levels in the blood affect the way the lung functions, and can result in a greater number of infections (asthmatics suffer more viral infections than non-asthmatics). The increases recorded in this trial could help to explain improvements in peak flow readings and in themselves suggest improved lung function.

In addition, all the participants commented that their breathing had improved, most said they had used their inhalers less frequently and some even reported not having used their inhalers at all for periods of up to two weeks! Increased energy levels and less fatigue was experienced after doing normal tasks. 8 McConnell et al, Sports Medicine and Human Performance Unit, School of Sports and Exercise Sciences and Department of Medicine, University of Birmingham 1998.

The Friends of Asthma trial concludes that the increase in peak flow readings, with the implied and recorded improvements in asthma, and the reduction of the use of possibly harmful medication, are potentially very significant for the treatment of asthma.

Made from only the purest natural plant substances sourced from the clean southern seas lying between New Zealand and Antarctica, Cellfood Concentrate is available from leading Health Stores and Pharmacies nationwide.